JEMPERLI 500 mg CONCENTRADO PARA SOLUCION PARA PERFUSION

Glaxosmithkline Trading Services Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: eb3c34687dab0357
Drug Cima Aemps Name: JEMPERLI 500 mg CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1211538001
Holder Company Name: Glaxosmithkline Trading Services Limited
Marketing Company Name: Glaxosmithkline S.A.
Holder Company Detail Path: /organization/glaxosmithkline-trading-services-limited
Marketing Company Detail Path: /organization/glaxosmithkline-sa
Authorization Date: 2021-05-24
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 500 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Glaxosmithkline Trading Services Limited
Company Detail Path: /organization/glaxosmithkline-trading-services-limited

DOSTARLIMAB

500 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 24, 2021

Approval ID

eb3c34687dab0357

Type

Standard